AI-generated summary
The authors compared 0.5% topical timolol cream with 595-nm pulsed dye laser in 21 infants with superficial proliferating hemangiomas, with each lesion split so each treatment was applied to one part. Five blinded assessors judged photographs, and the authors report that pulsed dye laser gave significantly better visual results than timolol over a short follow-up. No permanent side effects were reported. The authors note that longer follow-up and larger samples are needed.
- Participants
- 21
- Who or what was studied
- Infants with superficial proliferating infantile hemangiomas
- Wavelengths
- 595 nm
- Limits stated in the abstract
- Small pilot study with short 2 to 6 month follow-up, open-label design, and the authors state that larger samples and longer follow-up are required to validate the findings.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser, Pilot study, Sample size. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.